MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Arvinas ROE Ratio 2011-2026 | ARVN
Annual ROE Ratio Arvinas
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.62 | -35.41 | -55.65 | -50.01 | -24.43 | -18.58 | -31.01 | -30.35 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -18.58 | -55.65 | -33.01 |
Quarterly ROE Ratio Arvinas
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.1 | -14.28 | -10.1 | -25.64 | -39.64 | -45.24 | -53.74 | -44.39 | -55.04 | -51.7 | -47.77 | -29.86 | -35.58 | -30.65 | -28.84 | -21.01 | -25.81 | -24.89 | -20.19 | -12.11 | -21.4 | -24.4 | -28.04 | -31.01 | -33.5 | -35.5 | -33.67 | -30.36 | -10.86 | 9.38 | 15.13 | 18.17 | 10.45 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.17 | -55.04 | -24.98 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ADC Therapeutics SA
ADCT
|
-138.5 | $ 3.78 | - | $ 105 M |  Schweiz |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Akebia Therapeutics
AKBA
|
-16.39 | $ 1.35 | -2.17 % | $ 347 M |  USA |
 |
Akari Therapeutics, Plc
AKTX
|
-61.06 | $ 3.5 | -21.7 % | $ 236 B |  Britain |
 |
Aldeyra Therapeutics
ALDX
|
-76.49 | $ 1.58 | -4.82 % | $ 94.9 M | USA |
 |
Aligos Therapeutics
ALGS
|
-45.18 | $ 8.36 | 4.89 % | $ 82.6 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
39.76 | $ 330.71 | 3.72 % | $ 43.3 B | USA |
 |
Altimmune
ALT
|
-39.17 | $ 3.47 | 3.89 % | $ 306 M | USA |
 |
ALX Oncology Holdings
ALXO
|
-391.42 | $ 1.98 | 0.25 % | $ 106 M | USA |
 |
Amgen
AMGN
|
89.06 | $ 346.45 | -0.43 % | $ 186 B | USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M |  China |
 |
Amneal Pharmaceuticals
AMRX
|
-101.78 | $ 12.37 | -0.92 % | $ 3.88 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | France |
 |
Anika Therapeutics
ANIK
|
-38.95 | $ 15.0 | 1.32 % | $ 220 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
-4.59 | $ 76.34 | 2.87 % | $ 1.47 B | USA |
 |
Annexon
ANNX
|
-97.66 | $ 5.64 | 2.45 % | $ 875 M | USA |
 |
Aptorum Group Limited
APM
|
-20.19 | $ 0.92 | -1.11 % | $ 5.02 M | China |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Aprea Therapeutics
APRE
|
-101.27 | $ 0.73 | 2.63 % | $ 4.77 M | USA |
 |
Aquestive Therapeutics
AQST
|
248.9 | $ 4.15 | 0.48 % | $ 444 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
-30.74 | $ 8.43 | 4.98 % | $ 231 M |  Israel |
 |
Ardelyx
ARDX
|
-36.9 | $ 6.08 | 2.27 % | $ 1.47 B | USA |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 23.93 | 1.27 % | $ 3.04 B | USA |
 |
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
-0.35 | $ 61.57 | 0.88 % | $ 8.24 B | USA |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Assembly Biosciences
ASMB
|
-2.96 | $ 30.01 | 3.43 % | $ 336 M | USA |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | USA |
 |
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Actinium Pharmaceuticals
ATNM
|
-432.56 | $ 1.14 | 16.28 % | $ 35.6 M | USA |
 |
Atossa Therapeutics
ATOS
|
-88.35 | $ 5.21 | -2.89 % | $ 44.9 M | USA |
 |
Atara Biotherapeutics
ATRA
|
-84.9 | $ 5.03 | 0.7 % | $ 63.1 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
36.26 | $ 16.04 | 2.75 % | $ 2.16 B | Canada |
 |
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.42 | 0.35 % | $ 378 M | Britain |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
-294.78 | - | 10.36 % | $ 9.8 M | USA |